In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

INC Research Holdings, Inc.

http://incresearch.com

Latest From INC Research Holdings, Inc.

From Whiskey To Cancer Drugs: George Nakayama’s Unusual Journey

From extricating Daiichi Sankyo from the Ranbaxy acquisition to enabling the rapid development of blockbuster Enhertu, George Nakayama has had a winding career path through multiple key strategic positions and decisions. He shares his experience and insights, and a good dose of humor, in this exclusive interview.

Leadership Strategy

BioNTech Eyes First Oncology Approvals By 2026

CEO U

Business Strategies ImmunoOncology

GSK Seeks To Prevent Pfizer From Selling Its Rival RSV Vaccine In the US

Claiming Pfizer’s Abrysvo infringes four of its patents, GSK asks court to permanently enjoin Pfizer from making or selling the vaccine in the US but would exempt the pending maternal indication.

Intellectual Property Legal Issues

Five Key Takeaways From Merck’s Q2 Earnings Release

Keytruda and Gardasil lead Merck’s growth story, although Lagevrio’s ongoing decline placed a drag on quarterly performance. Lung cancer is driving Keytruda’s momentum outside the US.

Sales & Earnings Pricing Debate
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Medical Devices
  • Pharmaceuticals
  • Services
UsernamePublicRestriction

Register